Detalhe da pesquisa
1.
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
Anticancer Drugs
; 34(3): 413-421, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730619
2.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
3.
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Future Oncol
; 18(28): 3151-3164, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929414
4.
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 22(2)2021 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33477700
5.
Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
J Vasc Interv Radiol
; 31(12): 2066-2072, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127247
6.
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm.
J Eur Acad Dermatol Venereol
; 38(1): e99-e101, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607297
7.
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Breast Cancer Res
; 20(1): 72, 2018 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996899
8.
Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Breast Cancer Res
; 24(1): 53, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869494
9.
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
Br J Cancer
; 117(2): 164-170, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28641315
10.
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Cell Physiol Biochem
; 44(2): 594-606, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29161698
11.
ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Cancer Invest
; 33(4): 107-13, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647444
12.
Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma.
Future Oncol
; 11(6): 997-1009, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25760979
13.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636208
14.
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).
Breast Cancer Res Treat
; 148(3): 591-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25399229
15.
The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach.
NPJ Prim Care Respir Med
; 34(1): 5, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684681
16.
Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
Front Mol Biosci
; 11: 1413164, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715706
17.
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Melanoma Res
; 34(2): 152-165, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092014
18.
Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.
Expert Rev Mol Diagn
; 24(1-2): 89-98, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193169
19.
LKB1 Loss Correlates with STING Loss and, in Cooperation with ß-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.
Cancers (Basel)
; 16(10)2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791897
20.
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis.
Cancers (Basel)
; 16(10)2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38792001